Lusutrombopag is Effective and Safe in Patients with Chronic Liver Disease and Severe Thrombocytopen...
Lusutrombopag is Effective and Safe in Patients with Chronic Liver Disease and Severe Thrombocytopenia: A Multicenter Retrospective Study
About this item
Full title
Author / Creator
Publisher
Durham: Research Square
Journal title
Language
English
Formats
Publication information
Publisher
Durham: Research Square
Subjects
More information
Scope and Contents
Contents
Background: Chronic liver disease (CLD) is often complicated by severe thrombocytopenia (platelet count <50,000/µL). Platelet transfusion has been a gold standard for increasing the platelet count to prevent hemorrhagic events in such patients. Lusutrombopag, a thrombopoietin receptor agonist, can increase the platelet count in such patients when i...
Alternative Titles
Full title
Lusutrombopag is Effective and Safe in Patients with Chronic Liver Disease and Severe Thrombocytopenia: A Multicenter Retrospective Study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2539344797
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2539344797
Other Identifiers
DOI
10.21203/rs.3.rs-79320/v1
How to access this item
https://www.proquest.com/docview/2539344797?pq-origsite=primo&accountid=13902
